New York 2023-2024 Regular Session

New York Senate Bill S05304

Introduced
3/1/23  
Refer
3/1/23  

Caption

Relates to the definition of the practice of pharmacy; provides that the state board of pharmacy shall not adopt any rules authorizing a pharmacist to prescribe a controlled drug; repeals provisions related to the collaborative drug therapy management demonstration program.

Companion Bills

No companion bills found.

Previously Filed As

NY HB1582

Pharmacists; collaborative agreements, drug therapy.

NY HB3273

Relating to the licensing and regulation of pharmacies, pharmacists, and pharmacy technicians.

NY HB698

Relating to certain protected practices of pharmacists and pharmacies regarding amounts charged for prescription drugs.

NY HB2490

Pharmacists; providers; collaborative practice agreements

NY SB01102

An Act Concerning Pharmacies And Pharmacists.

NY S357

Pharmacists/Collaborative Practice

NY S597

Pharmacists/Collaborative Practice

NY HB1696

Relating to the regulation of pharmacy benefit managers and to payment of claims to pharmacies and pharmacists.

NY SB460

Relating to the licensing and regulation of pharmacists and pharmacies.

NY S0482

Amends the types of products which pharmacists may prescribe as substitute drugs or products to include "devices and supplies" and "therapeutically equivalent drugs and pharmaceuticals".

Similar Bills

No similar bills found.